These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

553 related articles for article (PubMed ID: 1372480)

  • 1. Inhibition by sodium nitroprusside or PGE1 of tyrosine phosphorylation induced in platelets by thrombin or ADP.
    Oda A; Druker BJ; Smith M; Salzman EW
    Am J Physiol; 1992 Mar; 262(3 Pt 1):C701-7. PubMed ID: 1372480
    [TBL] [Abstract][Full Text] [Related]  

  • 2. Concentration and regulation of cyclic nucleotides, cyclic-nucleotide-dependent protein kinases and one of their major substrates in human platelets. Estimating the rate of cAMP-regulated and cGMP-regulated protein phosphorylation in intact cells.
    Eigenthaler M; Nolte C; Halbrügge M; Walter U
    Eur J Biochem; 1992 Apr; 205(2):471-81. PubMed ID: 1315268
    [TBL] [Abstract][Full Text] [Related]  

  • 3. Role of cGMP and cGMP-dependent protein kinase in nitrovasodilator inhibition of agonist-evoked calcium elevation in human platelets.
    Geiger J; Nolte C; Butt E; Sage SO; Walter U
    Proc Natl Acad Sci U S A; 1992 Feb; 89(3):1031-5. PubMed ID: 1310537
    [TBL] [Abstract][Full Text] [Related]  

  • 4. Elevation of cAMP, but not cGMP, inhibits thrombin-stimulated tyrosine phosphorylation in human platelets.
    Pumiglia KM; Huang CK; Feinstein MB
    Biochem Biophys Res Commun; 1990 Sep; 171(2):738-45. PubMed ID: 1698364
    [TBL] [Abstract][Full Text] [Related]  

  • 5. Vasodilator-stimulated protein phosphorylation in platelets is mediated by cAMP- and cGMP-dependent protein kinases.
    Waldmann R; Nieberding M; Walter U
    Eur J Biochem; 1987 Sep; 167(3):441-8. PubMed ID: 2820726
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Cyclic nucleotides modulate store-mediated calcium entry through the activation of protein-tyrosine phosphatases and altered actin polymerization in human platelets.
    Rosado JA; Porras T; Conde M; Sage SO
    J Biol Chem; 2001 May; 276(19):15666-75. PubMed ID: 11278478
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Endogenous ADP prevents PGE1-induced tyrosine dephosphorylation of focal adhesion kinase in thrombin-activated platelets.
    Vostal JG; Shafer B; Mondoro TH; Fratantoni JC
    Biochim Biophys Acta; 1996 Nov; 1314(1-2):1-12. PubMed ID: 8972712
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Phosphorylation of focal adhesion vasodilator-stimulated phosphoprotein at Ser157 in intact human platelets correlates with fibrinogen receptor inhibition.
    Horstrup K; Jablonka B; Hönig-Liedl P; Just M; Kochsiek K; Walter U
    Eur J Biochem; 1994 Oct; 225(1):21-7. PubMed ID: 7925440
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Dipyridamole enhances NO/cGMP-mediated vasodilator-stimulated phosphoprotein phosphorylation and signaling in human platelets: in vitro and in vivo/ex vivo studies.
    Aktas B; Utz A; Hoenig-Liedl P; Walter U; Geiger J
    Stroke; 2003 Mar; 34(3):764-9. PubMed ID: 12624305
    [TBL] [Abstract][Full Text] [Related]  

  • 10. Thrombin-stimulated phospholipase C activity is inhibited without visible delay by a rapid increase in the cyclic GMP levels induced by sodium nitroprusside.
    Azula FJ; Alzola ES; Conde M; Trueba M; Macarulla JM; Marino A
    Mol Pharmacol; 1996 Aug; 50(2):367-79. PubMed ID: 8700145
    [TBL] [Abstract][Full Text] [Related]  

  • 11. Synergistic phosphorylation of the focal adhesion-associated vasodilator-stimulated phosphoprotein in intact human platelets in response to cGMP- and cAMP-elevating platelet inhibitors.
    Nolte C; Eigenthaler M; Horstrup K; Hönig-Liedl P; Walter U
    Biochem Pharmacol; 1994 Oct; 48(8):1569-75. PubMed ID: 7980622
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Influence of the cGMP analog 8-PCPT-cGMP on agonist-induced increases in cytosolic ionized Ca2+ and on aggregation of human platelets.
    Menshikov MYu ; Ivanova K; Schaefer M; Drummer C; Gerzer R
    Eur J Pharmacol; 1993 May; 245(3):281-4. PubMed ID: 8392939
    [TBL] [Abstract][Full Text] [Related]  

  • 13. Dipyridamole synergizes with nitric oxide to prolong inhibition of thrombin-induced platelet shape change.
    Jensen BO; Kleppe R; Kopperud R; Nygaard G; Døskeland SO; Holmsen H; Selheim F
    Platelets; 2011; 22(1):8-19. PubMed ID: 20958117
    [TBL] [Abstract][Full Text] [Related]  

  • 14. Interaction of nitric oxide and cGMP with signal transduction in activated platelets.
    Nguyen BL; Saitoh M; Ware JA
    Am J Physiol; 1991 Oct; 261(4 Pt 2):H1043-52. PubMed ID: 1656783
    [TBL] [Abstract][Full Text] [Related]  

  • 15. Molecular basis of the synergistic inhibition of platelet function by nitrovasodilators and activators of adenylate cyclase: inhibition of cyclic AMP breakdown by cyclic GMP.
    Maurice DH; Haslam RJ
    Mol Pharmacol; 1990 May; 37(5):671-81. PubMed ID: 2160060
    [TBL] [Abstract][Full Text] [Related]  

  • 16. Stoichiometric and reversible phosphorylation of a 46-kDa protein in human platelets in response to cGMP- and cAMP-elevating vasodilators.
    Halbrügge M; Friedrich C; Eigenthaler M; Schanzenbächer P; Walter U
    J Biol Chem; 1990 Feb; 265(6):3088-93. PubMed ID: 2154470
    [TBL] [Abstract][Full Text] [Related]  

  • 17. Platelet shape change and Ca2+ mobilization induced by collagen, but not thrombin or ADP, are inhibited by phenylarsine oxide.
    Greenwalt DE; Tandon NN
    Br J Haematol; 1994 Dec; 88(4):830-8. PubMed ID: 7819106
    [TBL] [Abstract][Full Text] [Related]  

  • 18. Dual effects of oleic acid on Ca2+ mobilization and protein phosphorylation in human platelets in presence or absence of platelet activating factor.
    Kimoto M; Javors MA; Ekholm J; Siafaka-Kapadai A; Hanahan DJ
    Arch Biochem Biophys; 1992 Nov; 298(2):471-9. PubMed ID: 1384432
    [TBL] [Abstract][Full Text] [Related]  

  • 19. Regulation of protease-activated receptor (PAR) 1 and PAR4 signaling in human platelets by compartmentalized cyclic nucleotide actions.
    Bilodeau ML; Hamm HE
    J Pharmacol Exp Ther; 2007 Aug; 322(2):778-88. PubMed ID: 17525299
    [TBL] [Abstract][Full Text] [Related]  

  • 20. Interaction of antiplatelet drugs in vitro: aspirin, iloprost, and the nitric oxide donors SIN-1 and sodium nitroprusside.
    Negrescu EV; Grünberg B; Kratzer MA; Lorenz R; Siess W
    Cardiovasc Drugs Ther; 1995 Aug; 9(4):619-29. PubMed ID: 8547213
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 28.